Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/25/2014US8658649 Kinase inhibitor
02/25/2014US8658648 Modified chloroquines with single ring moiety or fused ring moiety
02/25/2014US8658647 Integrin-linked kinase inhibitors
02/25/2014US8658646 Pyrrolopyrazine kinase inhibitors
02/25/2014US8658645 Use of quinolone antibiotics
02/25/2014US8658644 Pyridazine derivatives, processes for their preparation and their use as fungicides
02/25/2014US8658643 Pyrimidinyl pyridazinone derivatives
02/25/2014US8658642 Arylsulfonamide CCR3 antagonists
02/25/2014US8658641 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
02/25/2014US8658640 JNK inhibitors for the treatment of endometriosis
02/25/2014US8658639 N-substituted-cyclic amino derivative
02/25/2014US8658638 Mineralocorticoid receptor antagonist and methods of use
02/25/2014US8658637 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
02/25/2014US8658636 TRPV4 antagonists
02/25/2014US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases
02/25/2014US8658634 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
02/25/2014US8658633 Methods and compositions for treating conditions of the eye
02/25/2014US8658632 Arachidonic acid analogs and methods for analgesic treatment using same
02/25/2014US8658631 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
02/25/2014US8658630 Allergen depressant and depression method
02/25/2014US8658629 Use of lanostane and Poria extract in treating cachexia
02/25/2014US8658628 Hormone delivery system and method
02/25/2014US8658627 Pregnancy hormone combination for treatment of autoimmune diseases
02/25/2014US8658626 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
02/25/2014US8658625 External preparation for treating painful skin wound
02/25/2014US8658624 Pharmaceutical compositions for preventing and treating eye pathologies
02/25/2014US8658623 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
02/25/2014US8658622 Methods and compositions for preventing and treating a disease related to glycan dysregulation
02/25/2014US8658621 Topical method for prompt relief of severe ascites
02/25/2014US8658620 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
02/25/2014US8658619 Methods of treating subclinical sun damage
02/25/2014US8658618 Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs
02/25/2014US8658617 Salts of HIV inhibitor compounds
02/25/2014US8658616 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus
02/25/2014US8658610 Replication-competent anti-cancer vectors
02/25/2014US8658607 Immunostimulatory G, U-containing oligoribonucleotides
02/25/2014US8658606 Antibacterial aminoglycoside analogs
02/25/2014US8658605 Bioactivity composition of Reevesia formosana
02/25/2014US8658600 Antineoplastic hydrogels, and enzyme-instructed preparations thereof
02/25/2014US8658570 Use of anthranilamide derivatives for controlling insects and spider mites by drenching, soil mixing, furrow treatment, drip application, soil, stem or flower injection, in hydroponic systems, by planting hole treatment or dip application, floating or seedbox application or by treating seed, and also for enhancing the stress tolerance of plants to abiotic stress
02/25/2014US8658433 Dye compounds as photoactive agents
02/25/2014US8658236 Alcoholic compositions having a lowered risk of acetaldehydemia
02/25/2014US8658224 Modified pectins, compositions and methods related thereto
02/25/2014US8658212 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
02/25/2014US8658208 Coated solid preparation
02/25/2014US8658207 Extended release tablet formulations of flibanserin and method for manufacturing the same
02/25/2014US8658206 Compositions comprising strontium and vitamin D and uses thereof
02/25/2014US8658193 Styptic storage and delivery
02/25/2014US8658192 Integrated antimicrobial and low fouling materials
02/25/2014US8658191 Disinfection agent for suction systems used in the field of medicine or dentistry
02/25/2014US8658190 Enhanced tuburculocidal activity and decreased fumes from glutaraldehyde disinfectant using acetate salts and alcohol
02/25/2014US8658189 Methods of treating acne
02/25/2014US8658185 Kit useful for treating tumors and lesions of the skin and the mucous membranes
02/25/2014US8658183 Antimicrobial parenteral formulation
02/25/2014US8658179 Glycosylated specificity exchangers
02/25/2014US8658170 Combination therapy with MDM2 and EFGR inhibitors
02/25/2014US8658161 Solubilized CoQ-10
02/25/2014US8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
02/25/2014US8658150 Polymer derived from linear polyethylenimine for gene transfer
02/25/2014US8658149 Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
02/25/2014US8658147 Polymer hydrogels and methods of preparation thereof
02/25/2014US8658146 Superabsorbent composition with tannins for odor control
02/25/2014US8658142 Cosmetic compositions having long lasting shine
02/25/2014US8658128 System and method for diagnosis and treatment
02/25/2014CA2783684C Inhibitors of diacylglycerol acyltransferase
02/25/2014CA2777632C Imidazole derivatives as casein kinase inhibitors
02/25/2014CA2748814C Methods for treating vascular leak syndrome
02/25/2014CA2747954C Phosphonate compounds
02/25/2014CA2684174C Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease
02/25/2014CA2659851C 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
02/25/2014CA2655286C Therapeutic or prophylactic agent for allergic dermatitis
02/25/2014CA2649243C An osmotic drug delivery system
02/25/2014CA2637308C Use of 4-imidazole derivatives for cns disorders
02/25/2014CA2636993C Pyrimidine derivatives used as pi-3 kinase inhibitors
02/25/2014CA2636217C Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
02/25/2014CA2630410C 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
02/25/2014CA2624170C Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
02/25/2014CA2621127C Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
02/25/2014CA2593439C Thiazole-4-carboxamide derivatives as mglur5 antagonists
02/25/2014CA2575645C Soluble amide & ester pyrazinoylguanidine sodium channel blockers
02/25/2014CA2538252C 4'-thionucleosides and oligomeric compounds
02/25/2014CA2510128C Composition, synthesis and therapeutic applications of polyamines
02/25/2014CA2469953C Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides
02/25/2014CA2376665C Novel tet repressor-based transcriptional regulatory proteins
02/25/2014CA2207252C Inhibitors of prenyl transferases
02/22/2014CA2787472A1 Protein kinase inhibitors
02/20/2014WO2014028931A2 Compounds and methods for treating mammalian gastrointestinal microbial infections
02/20/2014WO2014028914A1 Deuterated icotinib derivatives
02/20/2014WO2014028909A1 Stat3 inhibitors and their anticancer use
02/20/2014WO2014028886A1 Nutlin-3a for treatment of proliferative vitreoretinopathy
02/20/2014WO2014028883A1 Methods of treating of neurological diseases
02/20/2014WO2014028878A1 Pharmaceutical compositions of memantine
02/20/2014WO2014028868A1 Parenteral formulation of rasagiline
02/20/2014WO2014028847A1 Water soluble nitric oxide-releasing polyglucosamines and uses thereof
02/20/2014WO2014028829A1 Novel kappa opioid ligands
02/20/2014WO2014028805A1 Pyrrolopyrazoles as n-type calcium channel blockers
02/20/2014WO2014028803A1 Substituted pyrazoles as n-type calcium channel blockers
02/20/2014WO2014028801A1 Cyclopentylpyrazoles as n-type calcium channel blockers
02/20/2014WO2014028800A1 Substituted pyrazoles as n-type calcium channel blockers
02/20/2014WO2014028796A2 Preparation of desiccated liposomes for use in compressible delivery systems
1 ... 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 ... 7860